Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia
about
Antibiotics for community-acquired pneumonia in adult outpatientsTools for outcome prediction in patients with community acquired pneumonia.Higher diagnostic accuracy and cost-effectiveness using procalcitonin in the treatment of emergency medicine patients with fever (The HiTEMP study): a multicenter randomized study.An Elevated Glycemic Gap is Associated With Adverse Outcomes in Diabetic Patients With Community-Acquired PneumoniaCost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults.Capsule commentary on Michaelidis et al., Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults.Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study.Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?Compliance with Procalcitonin Algorithm Antibiotic Recommendations for Patients in Medical Intensive Care Unit.
P2860
Q24193127-B129C7A1-3786-413C-B437-F93E75C749DEQ30240254-CC7BE9FC-6FE4-40A3-B1EE-14A724AE9238Q35980415-973AC190-9947-4484-8711-2E438F1A1A96Q36153054-52946BF1-E4E8-440E-9665-1F54BCB56287Q37663059-93692A1C-4D07-49A0-B8A6-1ED21386D29EQ38510987-FB073084-0A57-42CB-846D-36A228FEFC4FQ40484571-289739CC-15C9-4A85-A9B6-FEF991F2BA6AQ41393065-6BA12B5C-17FF-4E4D-A80E-596F0D275192Q48015654-685B0B3C-9D70-4553-867F-846FD5DD42D8
P2860
Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia
@en
Cost-effectiveness of procalci ...... community acquired pneumonia.
@nl
type
label
Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia
@en
Cost-effectiveness of procalci ...... community acquired pneumonia.
@nl
prefLabel
Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia
@en
Cost-effectiveness of procalci ...... community acquired pneumonia.
@nl
P2093
P2860
P50
P1476
Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia
@en
P2093
Angela Wateska
M Patricia Nowalk
Mahlon Raymund
Michael J Fine
P2860
P2888
P304
P356
10.1007/S11606-013-2400-X
P577
2013-09-01T00:00:00Z